“inflammatory-bowel-disease” Archives

in
Entry Author Date Location
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials 08/11/20 National
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome 06/26/19 Boulder/Denver
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes 05/30/19 San Francisco
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Amgen Picks Provention to Continue Development of Celiac Disease Drug 11/05/18 New York
Microbiome Startup uBiome Expands into Drug Research with $83M 09/21/18 San Francisco
Dutch Biotech Raises $19M to Develop Psoriasis Drug Near San Diego 03/14/18 San Diego
Pandion Raises $58M to Bring Cancer-Fighting Tactics to Immune Disorders 01/18/18 Boston
Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug 05/30/17 San Francisco
Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More 04/07/17 National
Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction 10/17/16 New York
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
Celgene Touts Data From Early Study of Oral GI Drug 09/12/16 Boston
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
Synlogic Nabs $40M, Prepares To Put Modified Microbes Into Patients 02/17/16 Boston
In New York and Montreal, Versant Seeds Two New Biotech Startups 12/10/15 New York
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug 09/09/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
West Coast Biotech Roundup: CareFusion, Sunesis, Second Genome, Etc. 10/09/14 San Francisco
Page 1 of 2 next page »